证券代码：600080 股票简称：金花股份 编号：临 2025-049 金花企业（集团）股份有限公司 关于控股股东之一致行动人部分股份解除质押的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示: | 持股比例 | 2.94% | 2.83% | | --- | --- | --- | | 剩余被质押股份数量 | 0 | | | 剩余被质押数量占其所持股份比例 | 0 | | | 剩余被质押数量占公司总股本比例 | 0 | | | 剩余被冻结股份数量 | 0 | | | 剩余被冻结数量占其所持股份比例 | 0 | | | 剩余被冻结数量占公司总股本比例 | 0 | | 注：本次解除质押后，公司股份如有后续质押计划，公司将严格按照相关法 律法规的规定，及时履行信息披露义务。 二、股东累计质押股份情况 截至本公告披露日，公司控股股东、实际控制人及其一致行动人累计质押股 份情况如下： | | | | 本次解除质 | 本次解除质 | 占其所 | 占公司 | 已质押股份情况 | | 未质押股份情况 | | | -- ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600080 股票简称：金花股份（维权） 编号：临2025-047 金花企业（集团）股份有限公司 关于归还募集资金的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 金花企业（集团）股份有限公司（以下简称"公司"）于2024年12月4日召开第十届董事会第十三次会 议、第十届监事会第九次会议，审议通过了《关于使用部分闲置募集资金暂时补充流动资金的议案》， 同意公司使用不超过人民币1亿元闲置募集资金暂时补充流动资金，主要用于与公司主营业务相关的经 营活动，使用期限自公司董事会审议批准之日起12个月内，到期前将及时、足额将该部分资金归还至募 集资金专户。具体内容详见2024年12月6日在上海证券报及上海证券交易所网站披露的《关于使用部分 闲置募集资金暂时补充流动资金的公告》（公告编号：临2024-053号）。 2025年11月27日，公司已将上述用于暂时补充流动资金的募集资金合计人民币99,843,085.05元全部归还 至公司募集资金专户，并将上述募集资金归还情 ...

证券代码：600080 股票简称：金花股份 编号：临 2025-047 金花企业（集团）股份有限公司（以下简称"公司"）于 2024 年 12 月 4 日召开第十届董事会第十三次会议、第十届监事会第九次会议，审议通过了《关 于使用部分闲置募集资金暂时补充流动资金的议案》，同意公司使用不超过人民 币 1 亿元闲置募集资金暂时补充流动资金，主要用于与公司主营业务相关的经营 活动，使用期限自公司董事会审议批准之日起 12 个月内，到期前将及时、足额 将该部分资金归还至募集资金专户。具体内容详见 2024 年 12 月 6 日在上海证券 报及上海证券交易所网站披露的《关于使用部分闲置募集资金暂时补充流动资金 的公告》（公告编号：临 2024-053 号）。 2025 年 11 月 27 日，公司已将上述用于暂时补充流动资金的募集资金合计 人民币 99,843,085.05 元全部归还至公司募集资金专户，并将上述募集资金归还 情况通知了保荐机构及保荐代表人。 特此公告。 金花企业（集团）股份有限公司董事会 2025 年 12 月 2 日 金花企业（集团）股份有限公司 关于归还募集资金的公告 本公司董事会及全体董事保证本 ...

关于集中竞价减持已回购股份的进展公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 回购股份的基本情况 金花企业（集团）股份有限公司（以下简称"公司"）于 2024 年 2 月 23 日 至 2024 年 5 月 22 日期间通过集中竞价交易方式累计回购公司股份 20,557,582 股，占公司总股本的 5.51%。其中，用于员工持股计划或股权激励累计回购股份 2,750,000 股（占公司总股本 0.74%）；用于维护公司价值及股东权益累计回购股 份 17,807,582 股（占公司总股本 4.77%）。具体内容详见公司于 2024 年 5 月 22 日披露的《关于股份回购实施结果暨股份变动的公告》（公告编号：2024-037 号）。 减持计划的进展情况 公司于 2025 年 10 月 30 日披露了《金花企业（集团）股份有限公司关于回 购股份集中竞价减持计划的公告》（公告编号：2025-044 号），自前述减持计划 公告披露之日起 15 个交易日后的六个月内，通过集中竞价交易方式，按市场价 格减 ...

Core Viewpoint - Jinhua Co., Ltd. experienced a stock price decline of 2.22% on December 1, with a current price of 8.36 CNY per share and a total market capitalization of 3.121 billion CNY [1] Group 1: Stock Performance - Year-to-date, Jinhua Co., Ltd. has seen a stock price increase of 7.43%, with a recent decline of 3.02% over the last five trading days [2] - Over the past 20 days, the stock price has increased by 7.46%, and over the past 60 days, it has risen by 11.91% [2] Group 2: Company Overview - Jinhua Co., Ltd. is located in Xi'an, Shaanxi Province, and was established on February 14, 1996, with its stock listed on June 12, 1997 [2] - The company's main business involves the research, production, and sales of pharmaceuticals, with 99.71% of its revenue coming from drug sales [2] - The company belongs to the pharmaceutical and biological industry, specifically in the traditional Chinese medicine sector [2] Group 3: Financial Performance - For the period from January to September 2025, Jinhua Co., Ltd. reported operating revenue of 384 million CNY, a year-on-year decrease of 8.36% [2] - The net profit attributable to the parent company was 34.4812 million CNY, reflecting a year-on-year increase of 12.06% [2] Group 4: Shareholder Information - As of September 30, the number of shareholders for Jinhua Co., Ltd. was 20,100, a decrease of 2.22% from the previous period [2] - The average circulating shares per person increased by 2.27% to 18,574 shares [2] Group 5: Dividend Information - Since its A-share listing, Jinhua Co., Ltd. has distributed a total of 118 million CNY in dividends, with 10.5814 million CNY distributed over the past three years [3]

Core Viewpoint - Jinhua Co., Ltd. has experienced a stock price increase of 13.08% year-to-date, with significant gains in recent trading periods, indicating positive market sentiment despite a slight decline on November 26 [2]. Group 1: Stock Performance - As of November 26, Jinhua's stock price was reported at 8.80 CNY per share, with a trading volume of 77.9 million CNY and a turnover rate of 2.34%, resulting in a total market capitalization of 3.285 billion CNY [1]. - The stock has seen a price increase of 8.51% over the last five trading days, 16.87% over the last 20 days, and 11.39% over the last 60 days [2]. Group 2: Financial Performance - For the period from January to September 2025, Jinhua achieved a revenue of 384 million CNY, reflecting a year-on-year decrease of 8.36%, while the net profit attributable to shareholders was 34.48 million CNY, showing a year-on-year increase of 12.06% [2]. - The company's main business revenue is derived from pharmaceutical sales, accounting for 99.71% of total revenue, with other income contributing 0.29% [2]. Group 3: Shareholder Information - As of September 30, the number of shareholders for Jinhua was 20,100, a decrease of 2.22% from the previous period, with an average of 18,574 circulating shares per shareholder, which is an increase of 2.27% [2]. Group 4: Dividend Information - Since its A-share listing, Jinhua has distributed a total of 118 million CNY in dividends, with 10.58 million CNY distributed over the past three years [3].

Group 1 - Beijing Junzheng adjusted management expenses by 11.44 million yuan, increasing net profit by the same amount [1] - Ningbo Energy's subsidiary plans to publicly transfer 15% equity of Lingfeng Energy at a base price of 16.06 million yuan [1] - Dongjiang Environmental's subsidiary was fined 2.02 million yuan for tax evasion [1][2] Group 2 - AVIC's subsidiary Harbin Aircraft Industry Group plans to absorb and merge with Harbin Hafei Aviation, increasing registered capital to 3.038 billion yuan [3] - Dongfang Ocean's shareholder plans to reduce holdings by up to 3% of total shares [4] - Xinghui Entertainment's controlling shareholder plans to reduce holdings by up to 2.9% of total shares [6] Group 3 - Kaineng Health plans to acquire 100% equity of four subsidiaries for 204 million yuan [8] - Suoao Sensor's controlling shareholder changed to Zhongchuang Innovation [9] - Shanghai Port Bay reported that its commercial aerospace and perovskite solar business accounts for less than 1% of revenue [10] Group 4 - Zhonghuan Environmental's specific shareholder plans to reduce holdings by up to 2.37% of total shares [11] - Xinlaifu's asset management plan intends to reduce 874,300 shares [12] - Guangdian Measurement plans to invest 800 million yuan to build a testing base [13] Group 5 - Modern Investment plans to invest 1.04 billion yuan to establish a smart logistics company [14] - Gaole Co.'s major shareholder is planning a control change, leading to stock suspension [16] - Weiling Co.'s major shareholder is planning a control change, leading to stock suspension [18] Group 6 - Igor plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange [20] - Huanrui Century's shareholder sold 7.26 million shares due to judicial enforcement [21] - Jinhua Co.'s controlling shareholder plans to acquire 5.77% of company shares at 9.15 yuan per share [22] Group 7 - Wireless Media's four shareholders plan to reduce holdings by up to 4.7% of total shares [24] - CATL's shareholder completed the transfer of 10% of shares for approximately 17.16 billion yuan [26] - *ST Lian Stone entered the restructuring phase, with potential downward adjustment of stock price [28]

金花股份表示，本次协议转让系公司控股股东、实际控制人邢博越及其一致行动人之间内部转让，其合 计持股比例、数量和表决权未发生变化。 北京商报讯（记者 丁宁）11月25日，金花股份（600080）发布公告称，公司控股股东、实际控制人邢 博越及其一致行动人杜玲、杨蓓签订了《股权转让协议书》，杜玲、杨蓓拟通过协议转让的方式分别将 各自持有的公司1097.42万股（占公司总股本的2.94%）、1054.56万股（占公司总股本的2.83%），合计 2151.98万股（占公司总股本的5.77%）转让予邢博越。 ...

格隆汇11月24日丨金花股份（维权）(600080.SH)公布，2025年11月24日，公司控股股东、实际控制人 邢博越及其一致行动人杜玲、杨蓓签订了《股权转让协议书》，杜玲、杨蓓拟通过协议转让的方式分别 将各自持有的公司10,974,247股（占公司总股本的2.94%）、10,545,559股（占公司总股本的2.83%）， 合计21,519,806股（占公司总股本的5.77%）转让予邢博越。邢博越承诺在上述股权转让过户完成之日 起12个月内不减持所持有的公司股份。 本次协议转让系公司控股股东、实际控制人邢博越及其一致行动人之间内部转让，其合计持股比例、数 量和表决权未发生变化。不涉及向市场减持，不触及要约收购，不会导致公司控股股东及实际控制人发 生变化。本次协议转让前，邢博越持有公司73,272,546股（占公司总股本的19.63%），邢博越及其一致 行动人合计持有公司94,792,352股（占公司总股本的25.40%）。本次协议转让后，邢博越持有公司 94,792,352股（占公司总股本的25.40%），杜玲、杨蓓将不再持有公司股份。 ...

智通财经APP讯，金花股份(600080.SH)公告，公司控股股东、实际控制人邢博越及其一致行动人杜 玲、杨蓓签订了《股权转让协议书》，杜玲、杨蓓拟通过协议转让的方式将合计2151.98万股(占公司总 股本的5.77%)转让予邢博越。邢博越承诺在上述股权转让过户完成之日起12个月内不减持所持有的公司 股份。本次协议转让系公司控股股东、实际控制人邢博越及其一致行动人之间内部转让，其合计持股比 例、数量和表决权未发生变化。本次协议转让后，杜玲、杨蓓将不再持有公司股份。 ...